|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income | ||
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Transaction costs allocated to warrant liabilities | ||
| Amortization of prepaid expenses | ||
| Change in fair value of warrant liabilities | ||
| Change in fair value of convertible promissory note | ||
| Interest earned on investments held in Trust Account | ||
| Changes in assets and liabilities: | ||
| Prepaid expenses | ||
| Accrued offering costs and expenses | ||
| Due to related party | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Investments held in trust account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds from issuance of founder shares | ||
| Proceeds received from public offerings, net of underwriters' discount | ||
| Proceeds from convertible promissory note | ||
| Proceeds from private placement | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Cash, beginning of the period | ||
| Cash, end of the period | ||
| Net change in cash | ||
| Cash and cash equivalents, beginning of the period | ||
| Cash and cash equivalents, end of the period | ||
| Supplemental disclosure of cash flow information: | ||
| Deferred underwriter's discount | ||
| Remeasurement adjustment on redeemable Class A ordinary shares | ||
| Initial measurement of warrant liabilities |
Loading...
